Biotech 2050 Podcast
Episodes
50. Noninvasive diagnostics for NASH and inflammatory indications, Caroline Loew, CEO, Glympse Bio
17 Mar 2021
Contributed by Lukas
Caroline is a biopharmaceutical executive with over 20 years of experience successfully leading diverse, empowered, and integrated teams. She has broa...
49. Restoring connections for neurodegenerative diseases, Leen Kawas, CEO, Athira Pharma
10 Mar 2021
Contributed by Lukas
Leen Kawas, Ph.D., has served as our chief executive officer and as a member of our board of directors since January 2014. Previously, Dr. Kawas serve...
48. Anti-TNF: From Arthritis to Dementia and Fibrosis, Jim Woody, CEO, 180 Life Sciences
03 Mar 2021
Contributed by Lukas
Jim Woody has more than 25 years of pharmaceutical research and management expertise He currently serves as Chairman of Oncomed Pharmaceuticals, wher...
47. Next generation cell-free cancer and autoimmune therapeutics, Bill Newell, CEO, Sutro Biopharma
24 Feb 2021
Contributed by Lukas
William J. Newell has served as our Chief Executive Officer and a member of our Board of Directors since January 2009. Previously, he served as the Pr...
46. Fighting cancer with protein degradation, Adam Crystal, CMO, Stew Fisher, CSO, C4 Therapeutics
17 Feb 2021
Contributed by Lukas
Adam Crystal, M.D., Ph.D. joined C4 Therapeutics in February 2019 as our Chief Medical Officer. Previously, Adam was at Novartis Institutes for Biomed...
45. Next generation of cell therapy, Brian Culley, CEO, Lineage Cell Therapeutics
10 Feb 2021
Contributed by Lukas
Mr. Culley joined Lineage as Chief Executive Officer in September 2018. Prior to joining Lineage, Mr. Culley served from August 2017 to September 2018...
44. Revolutionizing the drug discovery marketplace, Kevin Lustig, Founder and CEO, Scientist.com
03 Feb 2021
Contributed by Lukas
Kevin is a scientist-entrepreneur with 30 years of research experience in academia and pharma. He co-founded Scientist.com in 2007. In 2001, he co-fou...
43. From health economics to COVID19 treatment, Jonathan Javitt, Co-Founder and CEO, NeuroRx Pharma
27 Jan 2021
Contributed by Lukas
Dr. Javitt has played leadership roles in seven successful healthcare IT and biopharma startups with public exits. He has additionally led drug-develo...
42. Combating COVID19, Mei Mei Hu, Co-Founder and CEO, and Peter Diamandis, Co-Founder, COVAXX
20 Jan 2021
Contributed by Lukas
Mei Mei Hu: Mei Mei is also CEO of United Neuroscience and a member of the executive committee of United Biomedical, Inc. She oversaw the launch of on...
41. Tackling the mental health pandemic, Shawn Singh, CEO, VistaGen Therapeutics
13 Jan 2021
Contributed by Lukas
Shawn Singh has served as our Chief Executive Officer since August 2009; he joined our Board of Directors in 2000. Mr. Singh has nearly 30 years of ex...
40. Approaches to immunology, inflammation, and oncology, Dr. Luisa Salter-Cid, CSO, Gossamer Bio
06 Jan 2021
Contributed by Lukas
Dr. Salter-Cid brings to Gossamer Bio over 20 years of drug discovery experience in the biotech and pharmaceutical industries and spent the last 13 ye...
39. Biotech2050 Season 1 Wrap Up: Co-Hosts, Alok Tayi and Rahul Chaturvedi
16 Dec 2020
Contributed by Lukas
Thank you for your support for Season 1! We reflect and look forward to Season 2 on this episode! Learn more about our co-hosts below! Alok Tayi is t...
38. AI-driven early detection cancer screening from a blood test, Ken Chahine, CEO, Helio Health
11 Nov 2020
Contributed by Lukas
As Executive Vice President and General Manager of Ancestry.com, a 1.6 billion dollar technology company, Ken led the launch of AncestryDNA, a large-s...
37. Bringing new treatments to psychiatric orphan diseases, Ibs Mahmood, CEO, AMO Pharma
04 Nov 2020
Contributed by Lukas
Ibraheem Mahmood has an extensive life science and finance background that spans more than 20 years. His experience includes previous roles in Lifesci...
36. Harnessing the innate immune system to combat disease, RJ Tesi, CEO and CMO, INmune Bio
28 Oct 2020
Contributed by Lukas
Dr. Raymond J. Tesi has been President, Chief Executive Officer and acting Chief Medical Officer since the formation of INmune Bio in September 2015. ...
35. Continuous manufacturing in drug development, Matthew Bio, CEO, Snapdragon Chemistry
21 Oct 2020
Contributed by Lukas
Dr. Matthew Bio is President & CEO at Snapdragon Chemistry. Matthew began his career in chemistry more than 20 years ago developing continuous proces...
34. Automation and Regenerative Manufacturing, Alexander Titus, Chief Strategy Officer, ARMI
14 Oct 2020
Contributed by Lukas
Alexander Titus is the Founder of Bioeconomy.XYZ and the Chief Strategy Officer (CSO) at the Advanced Regenerative Manufacturing Institute (ARMI), whe...
33. RNA modification gene therapy for rare disorders, Jim Burns, CEO, Kathie Bishop, CSO, Locanabio
07 Oct 2020
Contributed by Lukas
James Burns, PhD, Chief Executive Officer, Locanabio James (Jim) Burns, Ph.D., joined Locanabio in December 2019 as CEO and Board member. Prior to jo...
32. Vaccine origins to combat COVID-19, Seth Lederman, Co-Founder/CEO, Tonix Pharmaceuticals
30 Sep 2020
Contributed by Lukas
Seth Lederman is a physician, scientist and founder and executive officer of innovative biopharmaceuticals companies. Prior to founding Tonix, among t...
31. Drug discovery for neurodegenerative diseases, Victor Hanson-Smith, Comp. Bio., Verge Genomics
23 Sep 2020
Contributed by Lukas
Victor Hanson-Smith is the Head of Computational Biology at Verge Genomics and is one of the world's leaders in mathematical modeling of eukaryotic ge...
30. Genetics and synthetic biology for trailblazing drug discovery, Maria Soloveychik, CEO, SyntheX
16 Sep 2020
Contributed by Lukas
Dr. Maria Soloveychik is the co-founder and CEO of SyntheX, a therapeutics company focused on accelerating drug discovery using synthetic biology. The...
29. Breakthrough imaging device for noninvasive cancer detection: Bob Proulx, CEO Imagion Biosystems
09 Sep 2020
Contributed by Lukas
Bob has been President of Imagion Biosystems since February 2015 and has led the company through the recent restructuring and recapitalization efforts...
28. Urology medtech for BPH with insights on patient care, VC, and more Nick Damiano, CEO, Zenflow
02 Sep 2020
Contributed by Lukas
Nick Damiano is a serial entrepreneur with broad experience in medical devices and digital health. He has 15 years of experience as a healthcare entre...
27. Harnessing the microbiome to combat type 2 diabetes: Colleen Cutcliffe, CEO, Pendulum
26 Aug 2020
Contributed by Lukas
Colleen Cutcliffe is the CEO and Co-Founder of Pendulum. She has over 15 years of experience leading and managing biology teams in academia, pharmaceu...
26. DNA testing to proactively inform treatment: Paul Billings, CMO, Natera
19 Aug 2020
Contributed by Lukas
Dr. Paul R. Billings is a board-certified internist and clinical geneticist, who also holds a PhD in Immunology, from Harvard University. He worked th...
25. The power of AI for precision drug discovery and development: Auransa Inc., Andy Protter, CSO
05 Aug 2020
Contributed by Lukas
Andy Protter, PhD. joined Auransa in January 2017 as Chief Scientific Officer with 35 years of pharmaceutical industry research and development experi...
24. JoyL Silva, GM, and Nicole Strauss Pipeline Development and Innovation Lead, Pfizer CentreOne
29 Jul 2020
Contributed by Lukas
JoyL is the General Manager of Pfizer CentreOne, a global contract development and manufacturing organization (CDMO) and a leading supplier of special...
23. Abbas Kazimi, VP of Business Development, Nimbus Therapeutics
22 Jul 2020
Contributed by Lukas
Abbas Kazimi is the Vice President, Head of Business Development at Nimbus Therapeutics, a biotechnology company harnessing quantum mechanics and comp...
22. Randy Schatzman, Ph.D.,CEO and Board Member, Bolt Biotherapeutics
15 Jul 2020
Contributed by Lukas
Dr. Randy Schatzman, Ph.D., is the chief executive officer and a board member of Bolt Biotherapeutics since 2019. He has over 30 years of biotechnolog...
21. Glenn Rosen, MD, Senior VP, Pre-Clinical Translational Sciences, Coherus BioSciences
09 Jul 2020
Contributed by Lukas
Dr. Glenn Rosen has spent the bulk of his career engaged in basic and translational research in cancer and fibrosis. From 1993-2014, Dr. Rosen held a ...
20. Diego Ardigò, MD, PhD, Head of Research and Development, Global Rare Diseases, Chiesi Group
01 Jul 2020
Contributed by Lukas
Diego is currently the Head of Research & Development of Global Rare Diseases at the Chiesi Group. Before this role, he was leading Chiesi’s develop...
19. Mike Clayman, MD, CEO and Co-Founder, Flexion Therapeutics
24 Jun 2020
Contributed by Lukas
Dr. Clayman is a co-founder of Flexion Therapeutics and has served as our President, Chief Executive Officer and as one of our directors since our inc...
18. Grace Colón, PhD, President and CEO, InCarda Therapeutics
17 Jun 2020
Contributed by Lukas
Dr. Colón brings over 25 years of experience in biopharma, genomics, healthcare and industrial biotechnology. In addition to her role at InCarda, she...
17. Sachin Chandran, PhD, Exec. Dir., Head of Pharmaceutical Sciences, Catabasis Pharmaceuticals
10 Jun 2020
Contributed by Lukas
Recorded in January 2020, we spoke with Sachin Chandran, who is currently Executive Director and Head of Pharmaceutical Sciences at Catabasis Pharmace...
16. Mike Novotny, Founder and CEO, Medrio
03 Jun 2020
Contributed by Lukas
Mike Novotny is the founder and CEO of Medrio. Mr. Novotny applies 20 years of experience in research and software to his eClinical SaaS vision. Prior...
15. David Mace, Co-Founder and CEO, SwiftScale Biologics
27 May 2020
Contributed by Lukas
David Mace is the Co-founder & CEO of SwiftScale Biologics, a life sciences startup based in San Francisco, California. SwiftScale Biologics accelerat...
14. David Bates, PhD, Co-Founder, Linus Health
20 May 2020
Contributed by Lukas
David Bates is a scientist, inventor, investor, and entrepreneur. He has co-founded several companies including Linus Health and Bode. He is a foundin...
13. Stephan Kontos, PhD, Co-Founder and CSO, Anokion
13 May 2020
Contributed by Lukas
Stephan is a co-Founder and Chief Scientific Officer at Anokion, bringing more than 15 years of research expertise in the fields of immunology, protei...
12. Robert Gould, PhD, President & CEO, and Owen Wallace, PhD, CSO, Fulcrum Therapeutics
04 May 2020
Contributed by Lukas
Robert J. Gould joined Fulcrum as president and CEO at the time of the company’s launch in 2016, bringing over 30 years of experience to the role. P...
11. Controllable cell and gene therapies, Paul Wotton, PhD, CEO, Obsidian Therapeutics
27 Apr 2020
Contributed by Lukas
Dr. Paul K. Wotton is the Chief Executive Officer at Obsidian Therapeutics. Obsidian is a biotechnology company pioneering controllable cell and gene ...
10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines
26 Feb 2020
Contributed by Lukas
Chris is Sr. Vice President, Technical Operations at Blueprint Medicines. He has over 25 years of commercial and clinical manufacturing experience in...
9. The next frontier in cancer treatment: Foghorn Therapeutics and Chromatin Dysregulation
23 Jan 2020
Contributed by Lukas
Carl P. Decicco is a biopharmaceutical veteran with over 30+ years of experience in the industry. Over the course of his career, Carl has played a cen...
8. Dr. Florian Wegener, Co-Founder and CEO of ZAGENO
07 Jan 2020
Contributed by Lukas
Dr. Florian Wegener is the co-founder and CEO of ZAGENO, an award-winning online marketplace serving the needs of research scientists. He is also a bo...
7. Raman Sehgal, Founder and Global President of Ramarketing
17 Dec 2019
Contributed by Lukas
Raman is the founder and global president of ramarketing - an international design, digital and PR agency that's in the business of helping ambitious ...
6. Kevin J. Bittorf, PhD: Consultant and Founder, Simulation LLC
10 Dec 2019
Contributed by Lukas
In this episode, guest Kevin Bittorf, founder of the Advancing Drug Development Forum and Don Dickerson sat down with host Alok Tayi to discuss trends...
5. Jon Hennek: Systems Innovation Team Co-Lead at Indigo Ag
03 Dec 2019
Contributed by Lukas
Jon Hennek co-leads the Systems Innovation Team at Indigo Ag. He co-founded the team—whose mission is to create a vision for what agriculture could ...
4. Sven Karlsson: Co-founder, COO and CBO of Platelet BioGenesis
05 Nov 2019
Contributed by Lukas
Sven Karlsson is the co-founder, chief operating officer and chief business officer of Platelet BioGenesis. In this episode of Biotech2050, Sven talks...
3. Dr. Jo Viney: Co-Founder, President and CSO of Pandion Therapeutics
29 Oct 2019
Contributed by Lukas
Dr. Jo Viney is an entrepreneurial scientist and experienced biotech executive. A self-described “drug-hunter”, she has successfully advanced a nu...
2. John Keilty: Chief Data Sciences Officer at Decibel Therapeutics
23 Oct 2019
Contributed by Lukas
John Keilty is the Chief Data Sciences Officer at Decibel Therapeutics and a Strategic advisor at Third Rock Ventures. He is a biologist and bioinform...
1. Lee Cooper: Patient advocate and Founder of Enlight Bio
15 Oct 2019
Contributed by Lukas
In this inaugural episode of Biotech2050, hosts Alok Tayi and Rahul Chatuverdi sits down with Lee Cooper, a seasoned biotech entrepreneur, lawyer, pa...
Welcome to the Biotech2050 Podcast
01 Oct 2019
Contributed by Lukas
This episode is a trailer launching our highly anticipated podcast, Biotech 2050. A think tank chronicling the disruptions changing the biotech indust...